Introducing a fashion line inspired by the two million Canadians affected by osteoporosis TORONTO, Feb. 6, 2019  – Models clad in stylish bubble wrap strutted down the Toronto Fashion Week® x […]

Osteoporosis Canada is saddened to announce the passing of Dr. Timothy M. Murray, founding member of Osteoporosis Canada. Dr. Murray was the Emeritus Professor of Medicine at the University of […]

Christine Thomas was only 42 when, bending to lift her newborn daughter, she fractured her spine. Diagnosed with five vertebral fractures as a result of unsuspected osteoporosis, she had no idea of the painful and transformative road she would have to travel to build stronger bones and reclaim her life.

Eleanor Mills was a woman living with significant bone loss who saw herself as “a bent lady looking like an inverted L” after sustaining multiple osteoporotic fractures. Her daughter, Helen, […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

SHARE YOUR STORY By using your voice to share your story, you can help raise awareness of a disease that affects 2 million Canadians. Your story can help our organization […]

Great Giving Challenge You Could Win $20,000 for Osteoporosis Canada! The Great Canadian Giving Challenge is a month-long initiative to help us raise much needed funds to support the over […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]